Valneva SE (VALN) Accumulated Expenses (2020 - 2025)
Valneva SE (VALN) posted quarterly Accumulated Expenses of $14.4 million for Q4 2025, down 3.55% year-on-year from $14.9 million in Q4 2024, and down 3.55% on a QoQ basis from $14.9 million in Q4 2024.
Valneva SE (VALN) Accumulated Expenses (2020 - 2025) Analysis & Trends
Valneva SE (VALN) has reported Accumulated Expenses for 6 consecutive years, with $14.4 million the latest figure, recorded in Q4 2025.
- Quarterly Accumulated Expenses fell 3.55% year-over-year to $14.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $14.4 million (down 3.55% YoY) and the FY2025 annual result came in at $14.4 million, down 3.55% from the prior year.
- Accumulated Expenses fell to $14.4 million in Q4 2025 per VALN's latest filing, from $14.9 million in the prior quarter.
- Over the last five years, Accumulated Expenses for VALN reached as high as $14.9 million in Q4 2024 and fell as low as $11.5 million in Q4 2021.
- A 5-year average of $12.8 million and a median of $12.3 million in 2022 frame the typical range for Accumulated Expenses.
- Annual changes were most pronounced in 2021 — Accumulated Expenses gained 21.7% — and 2025, when it dropped 3.55%.
- Year by year, Accumulated Expenses stood at $11.5 million in 2021, then climbed by 6.7% to $12.3 million in 2022, then increased by 0.34% to $12.3 million in 2023, then rose by 21.19% to $14.9 million in 2024, then fell by 3.55% to $14.4 million in 2025.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $14.4 million, $14.9 million, and $11.6 million for Q4 2025, Q4 2024, and Q2 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Valneva SE | 803.90 Mn | 680.66 Mn | 5.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14.39 Mn |
| Dec 31, 2024 | 14.92 Mn |
| Jun 30, 2024 | 11.55 Mn |
| Dec 31, 2023 | 12.31 Mn |
| Dec 31, 2022 | 12.26 Mn |
| Dec 31, 2021 | 11.49 Mn |
| Dec 31, 2020 | 9.45 Mn |